Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Peptide-MHC Complex
47%
T Cell Receptor
44%
Immunotoxin
35%
HLA-A2
34%
Tumor Cells
34%
Recombinant Antibody
34%
Recombinant
32%
T Cells
30%
MHC Class I
27%
High Affinity
23%
Tumor
22%
MHC Class II
22%
Fv Fragment
22%
Disulfide
21%
Major Histocompatibility Complex
21%
Recombinant Immunotoxin
18%
Tumor Antigen
18%
T Cell Epitope
18%
Cancer Treatment
14%
Cancer Cells
12%
T Cell Receptor-like Antibody
12%
TCR-like Antibody
12%
Fusion Protein
12%
Antigen-presenting Cells
12%
Antibody Fragment
12%
Antigen-specific
12%
Lysis
11%
Dendritic Cells
11%
Tumor-specific
11%
MHC Molecules
11%
Fine Specificity
11%
Autoimmune Disease
11%
K562 Cells
10%
Epitope
10%
Chimeric Antigen Receptor T Cells (CAR-T)
10%
Viral
10%
Melanoma
10%
Antitumor Activity
9%
Peptide Complexes
9%
Cancer Immunotherapy
9%
Antibody-mediated
9%
Variable Domains
9%
Gp100
9%
ScFv
8%
Pseudomonas Exotoxin
8%
Cancer Therapy
8%
In Cancer
8%
Monoclonal Antibody
8%
Antigen Presentation
8%
Specific Binding
8%
Immunology and Microbiology
Peptides
100%
T Cell Receptor
69%
T Cell
44%
Tumor Cell
36%
Recombinant Antibody
35%
Epitope
30%
Immunotoxin
30%
Major Histocompatibility Complex
25%
MHC Class I
21%
Single-Chain Variable Fragment
19%
Tumor Antigen
17%
Immunotherapy
15%
Antigen-Presenting Cell
14%
Dendritic Cell
14%
Exotoxin
13%
Cancer Cell
12%
Antigen Specificity
12%
Binding Antibody
12%
Antigen Presentation
11%
Infectious Agent
11%
Cytotoxic T Cell
11%
Disulfide Bond
11%
Target Cell
10%
CD8
9%
Complement Membrane Attack Complex
9%
Monoclonal Antibody
9%
Antineoplastic Activity
9%
Pseudomonas
8%
Phage Display
8%
Xenograft
8%
Autoimmune Disease
8%
Cytotoxicity
8%
Framework Region
8%
Cell Population
8%
Cytotoxic T-Cell
7%
Cell Surface
7%
Chimeric Antigen Receptor T-Cell
7%
C3b
7%
Chimeric Antigen Receptor
7%
P-Glycoprotein
7%
Viral Disease
7%
Serum (Blood)
6%
Cytomegalovirus
6%
Immune Response
6%
MHC Class II
6%
Heavy Chain
5%
Amino Acid Sequence
5%
Immune System
5%
Multidrug Resistance Protein 1
5%
Experimental Autoimmune Encephalomyelitis
5%